Neubond
Develops a stroke rehabilitation wristband designed to provide movement feedback that helps the brain relearn motor control.
Overview
Neubond is an Imperial spinout building a wrist-worn rehabilitation device for stroke recovery. The product is described as a wristband that “tells your brain you moved,” targeting patients and clinical rehabilitation settings focused on restoring motor function after stroke. The company’s differentiator is its neurorehabilitation approach packaged in a wearable form factor, translating Imperial research into a practical rehab tool. Neubond raised $2M in an undisclosed round in June 2026, with the financing described as a Japanese university VC’s first UK investment.
Funding History
Japanese university VC picks Imperial spinout for its first UK investment. Meet a £1.5M stroke rehab wristband that tells your brain you moved
Frequently Asked Questions
- How much funding does AI Funding track for Neubond?
- AI Funding tracks $2M for Neubond across 1 funding round in this database.
- Who are Neubond's investors?
- Neubond's investors include Waseda University Ventures, SFC Capital, New Wave Ventures.
- What does Neubond do?
- Neubond is an Imperial spinout building a wrist-worn rehabilitation device for stroke recovery. The product is described as a wristband that “tells your brain you moved,” targeting patients and clinical rehabilitation settings focused on restoring motor function after stroke. The company’s differentiator is its neurorehabilitation approach packaged in a wearable form factor, translating Imperial research into a practical rehab tool. Neubond raised $2M in an undisclosed round in June 2026, with the financing described as a Japanese university VC’s first UK investment.
- Where is Neubond headquartered?
- Neubond is headquartered in London, United Kingdom.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.